{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:04:34Z","timestamp":1789520674734,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-05048-1","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:59:02Z","timestamp":1782741542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In vitro cytotoxic and apoptotic effects of chitosan-coated gold nanoparticles on HT-29 human colorectal adenocarcinoma cells"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6102-8646","authenticated-orcid":false,"given":"Javad","family":"Jodat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6382-6657","authenticated-orcid":false,"given":"Mojtaba","family":"Aghaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6138-8203","authenticated-orcid":false,"given":"Alireza","family":"Ekrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5893-6379","authenticated-orcid":false,"given":"Dian","family":"Dayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7589-0325","authenticated-orcid":false,"given":"Mohammad Ali","family":"JalaliFar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"4","key":"5048_CR1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1166\/jbn.2008.015","volume":"4","author":"CR Patra","year":"2008","unstructured":"Patra CR, Verma R, Kumar S, Greipp PR, Mukhopadhyay D, Mukherjee P. Fabrication of gold nanoparticle for potential application in multiple myeloma. J Biomed Nanotechnol. 2008;4(4):499\u2013507.","journal-title":"J Biomed Nanotechnol"},{"issue":"3","key":"5048_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12032-026-03266-x","volume":"43","author":"M Aghaei","year":"2026","unstructured":"Aghaei M, Yousefi-Avarvand A, Saki N, Jalali Far MA. Evaluation of the effects of silver nanoparticles and ciprofloxacin on apoptotic gene expression (BAX, Bcl-2, and caspase-3) in NALM-6 acute lymphoblastic leukemia progenitor B cells. Med Oncol. 2026;43(3):131.","journal-title":"Med Oncol"},{"issue":"5","key":"5048_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"3","key":"5048_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11864-025-01295-8","volume":"26","author":"F Karimi","year":"2025","unstructured":"Karimi F, Aghaei M, Saki N. Impact of Genetic Polymorphisms on Treatment Outcomes of Proteasome Inhibitors and Immunomodulatory Drugs in Multiple Myeloma. Curr Treat Options Oncol. 2025;26(3):197\u2013212.","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"5048_CR5","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"5048_CR6","first-page":"e70351","volume":"8","author":"M Aghaei","year":"2025","unstructured":"Aghaei M, JalaliFar MA, Yousefi-Avarvand A, Bahreiny SS, Karamali N, Mansouri Z, et al. Update Prognostic Potency of Vascular Endothelial Growth Factor-A in the Acute Lymphoblastic Leukemia Landscape: A Meta-Analysis. Cancer Rep (Hoboken). 2025;8(9):e70351.","journal-title":"Cancer Rep (Hoboken)"},{"issue":"2","key":"5048_CR7","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72(2):338\u201344.","journal-title":"Gut"},{"issue":"11","key":"5048_CR8","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1136\/gut.2004.052704","volume":"53","author":"AJ Watson","year":"2004","unstructured":"Watson AJ. Apoptosis and colorectal cancer. Gut. 2004;53(11):1701\u20139.","journal-title":"Gut"},{"issue":"1","key":"5048_CR9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q Li","year":"2024","unstructured":"Li Q, Geng S, Luo H, Wang W, Mo Y-Q, Luo Q, et al. Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Signal Transduct Target Therapy. 2024;9(1):266.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"5048_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10238-026-02066-x","volume":"26","author":"M Aghaei","year":"2026","unstructured":"Aghaei M, Bahreiny SS, Mahdizade AH, Abbasi A, Magharati A, Yousefi-Avarvand A. Cytokine-Mediated tumor sensitization: mechanistic frameworks and therapeutic opportunities in cancer Immunotherapy. Clin Exp Med. 2026;26(1):135.","journal-title":"Clin Exp Med"},{"issue":"10","key":"5048_CR11","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.3390\/ijms20102454","volume":"20","author":"NI Ismail","year":"2019","unstructured":"Ismail NI, Othman I, Abas F, Lajis H, Naidu N. Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer. Int J Mol Sci. 2019;20(10):2454.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5048_CR12","doi-asserted-by":"publisher","first-page":"103460","DOI":"10.1016\/j.retram.2024.103460","volume":"72","author":"M Aghaei","year":"2024","unstructured":"Aghaei M, Khademi R, Far MAJ, Bahreiny SS, Mahdizade AH, Amirrajab N. Genetic variants of dectin-1 and their antifungal immunity impact in hematologic malignancies: A comprehensive systematic review. Curr Res Translational Med. 2024;72(4):103460.","journal-title":"Curr Res Translational Med"},{"issue":"10","key":"5048_CR13","first-page":"777","volume":"21","author":"S Sobhan Bahreiny","year":"2023","unstructured":"Sobhan Bahreiny S, Ahangarpour A, Asghar Hemmati A, Kazemzadeh R, Bastani MN, Reza Dabbagh M, et al. Circulating nesfatin-1 levels in women with polycystic ovary syndrome: A systematic review and meta-analysis. Int J Reprod Biomed. 2023;21(10):777\u201388.","journal-title":"Int J Reprod Biomed"},{"issue":"6","key":"5048_CR14","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s10552-013-0201-5","volume":"24","author":"CM Johnson","year":"2013","unstructured":"Johnson CM, Wei C, Ensor JE, Smolenski DJ, Amos CI, Levin B, et al. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control. 2013;24(6):1207\u201322.","journal-title":"Cancer Causes Control"},{"issue":"8","key":"5048_CR15","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/cancers16081530","volume":"16","author":"G Roshandel","year":"2024","unstructured":"Roshandel G, Ghasemi-Kebria F, Malekzadeh R. Colorectal Cancer: Epidemiology, Risk Factors, and Prevention. Cancers. 2024;16(8):1530.","journal-title":"Cancers"},{"issue":"10","key":"5048_CR16","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1007\/s43032-024-01676-8","volume":"31","author":"SS Bahreiny","year":"2024","unstructured":"Bahreiny SS, Ahangarpour A, Rajaei E, Sharifani MS, Aghaei M. Meta-Analytical and Meta-Regression Evaluation of Subclinical Hyperthyroidism\u2019s Effect on Male Reproductive Health: Hormonal and Seminal Perspectives. Reproductive Sci. 2024;31(10):2957\u201371.","journal-title":"Reproductive Sci"},{"issue":"1","key":"5048_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.molmed.2019.06.009","volume":"26","author":"KG Roth","year":"2020","unstructured":"Roth KG, Mambetsariev I, Kulkarni P, Salgia R. The Mitochondrion as an Emerging Therapeutic Target in Cancer. Trends Mol Med. 2020;26(1):119\u201334.","journal-title":"Trends Mol Med"},{"issue":"6","key":"5048_CR18","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrd3137","volume":"9","author":"S Fulda","year":"2010","unstructured":"Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discovery. 2010;9(6):447\u201364.","journal-title":"Nat Rev Drug Discovery"},{"issue":"7","key":"5048_CR19","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/s41418-022-01022-y","volume":"29","author":"L Sainero-Alcolado","year":"2022","unstructured":"Sainero-Alcolado L, Lia\u00f1o-Pons J, Ruiz-P\u00e9rez MV, Arsenian-Henriksson M. Targeting mitochondrial metabolism for precision medicine in cancer. Cell Death Differ. 2022;29(7):1304\u201317.","journal-title":"Cell Death Differ"},{"issue":"12","key":"5048_CR20","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/bjc.2016.152","volume":"114","author":"P Sancho","year":"2016","unstructured":"Sancho P, Barneda D, Heeschen C. Hallmarks of cancer stem cell metabolism. Br J Cancer. 2016;114(12):1305\u201312.","journal-title":"Br J Cancer"},{"key":"5048_CR21","doi-asserted-by":"crossref","unstructured":"Darvin P, Sasidharan Nair V, Editorial. Understanding mitochondrial dynamics and metabolic plasticity in cancer stem cells: Recent advances in cancer treatment and potential therapeutic approaches. Front Oncol. 2023;13.","DOI":"10.3389\/fonc.2023.1155774"},{"issue":"8","key":"5048_CR22","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.tcb.2023.03.009","volume":"33","author":"X-x Zheng","year":"2023","unstructured":"Zheng X-x, Chen J-j, Sun Y-b, Chen T-q, Wang J, Yu S. -c. Mitochondria in cancer stem cells: Achilles heel or hard armor. Trends Cell Biol. 2023;33(8):708\u201327.","journal-title":"Trends Cell Biol"},{"key":"5048_CR23","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Heredia JM, Carnero A. Role of Mitochondria in Cancer Stem Cell Resistance. Cells. 2020;9(7).","DOI":"10.3390\/cells9071693"},{"key":"5048_CR24","doi-asserted-by":"crossref","unstructured":"Anjum S, Ishaque S, Fatima H, Farooq W, Hano C, Abbasi BH et al. Emerging Applications of Nanotechnology in Healthcare Systems: Grand Challenges and Perspectives. Pharmaceuticals (Basel). 2021;14(8).","DOI":"10.3390\/ph14080707"},{"key":"5048_CR25","doi-asserted-by":"publisher","first-page":"1490980","DOI":"10.3389\/fnano.2024.1490980","volume":"6","author":"RSK Nisha, Sachan","year":"2024","unstructured":"Nisha, Sachan RSK, Singh A, Karnwal A, Shidiki A, Kumar G. Plant-mediated gold nanoparticles in cancer therapy: exploring anti-cancer mechanisms, drug delivery applications, and future prospects. Front Nanatechnol. 2024;6:1490980.","journal-title":"Front Nanatechnol"},{"issue":"1","key":"5048_CR26","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1515\/ntrev-2022-0502","volume":"11","author":"NO Alafaleq","year":"2022","unstructured":"Alafaleq NO, Alomari A, Khan MS, Shaik GM, Hussain A, Ahmed F, et al. Anticancer potential of gold nanoparticles (AuNPs) using a battery of in vitro tests. Nanatechnol Reviews. 2022;11(1):3292\u2013304.","journal-title":"Nanatechnol Reviews"},{"key":"5048_CR27","doi-asserted-by":"crossref","unstructured":"Sargazi S, Laraib U, Er S, Rahdar A, Hassanisaadi M, Zafar MN et al. Application of Green Gold Nanoparticles in Cancer Therapy and Diagnosis. Nanomaterials (Basel). 2022;12(7).","DOI":"10.3390\/nano12071102"},{"key":"5048_CR28","doi-asserted-by":"crossref","unstructured":"Kus-Li\u015bkiewicz M, Fickers P, Ben Tahar I. Biocompatibility and Cytotoxicity of Gold Nanoparticles: Recent Advances in Methodologies and Regulations. Int J Mol Sci. 2021;22(20).","DOI":"10.3390\/ijms222010952"},{"issue":"1010","key":"5048_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1259\/bjr\/59448833","volume":"85","author":"S Jain","year":"2012","unstructured":"Jain S, Hirst DG, O\u2019Sullivan JM. Gold nanoparticles as novel agents for cancer therapy. Br J Radiol. 2012;85(1010):101\u201313.","journal-title":"Br J Radiol"},{"key":"5048_CR30","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.actbio.2022.12.054","volume":"158","author":"L Sun","year":"2023","unstructured":"Sun L, Liu Y, Yang N, Ye X, Liu Z, Wu J, et al. Gold nanoparticles inhibit tumor growth via targeting the Warburg effect in a c-Myc-dependent way. Acta Biomater. 2023;158:583\u201398.","journal-title":"Acta Biomater"},{"issue":"6","key":"5048_CR31","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3892\/ol.2024.14723","volume":"28","author":"W He","year":"2024","unstructured":"He W, Yang F, Chen K, Zeng Q. Targeted gold nanoparticles for ovarian cancer (Review). Oncol Lett. 2024;28(6):589.","journal-title":"Oncol Lett"},{"issue":"5","key":"5048_CR32","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.drudis.2021.01.030","volume":"26","author":"X-Y Liu","year":"2021","unstructured":"Liu X-Y, Wang J-Q, Ashby CR Jr, Zeng L, Fan Y-F, Chen Z-S. Gold nanoparticles: Synthesis, physiochemical properties and therapeutic applications in cancer. Drug Discovery Today. 2021;26(5):1284\u201392.","journal-title":"Drug Discovery Today"},{"issue":"1","key":"5048_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1166\/rase.2015.1070","volume":"4","author":"SR Makhsin","year":"2015","unstructured":"Makhsin SR, Teoh PL, Razak KA. Synthesis of gold nanoparticles and its conjugation strategies to biomolecules for biomedical applications. Reviews Adv Sci Eng. 2015;4(1):3\u201321.","journal-title":"Reviews Adv Sci Eng"},{"key":"5048_CR34","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Torres AC, Zarate-Trivi\u00f1o DG, Lorenzo-Anota HY, \u00c1vila-\u00c1vila A, Rodr\u00edguez-Abrego C, Rodr\u00edguez-Padilla C. Chitosan gold nanoparticles induce cell death in HeLa and MCF-7 cells through reactive oxygen species production. Int J Nanomed. 2018:3235\u201350.","DOI":"10.2147\/IJN.S165289"},{"issue":"4","key":"5048_CR35","doi-asserted-by":"publisher","first-page":"357","DOI":"10.7150\/thno.10657","volume":"5","author":"M Kodiha","year":"2015","unstructured":"Kodiha M, Wang YM, Hutter E, Maysinger D, Stochaj U. Off to the organelles-killing cancer cells with targeted gold nanoparticles. Theranostics. 2015;5(4):357.","journal-title":"Theranostics"},{"key":"5048_CR36","doi-asserted-by":"crossref","unstructured":"Aldahhan R, Almohazey D, Khan FA, editors. Emerging trends in the application of gold nanoformulations in colon cancer diagnosis and treatment. Seminars in Cancer Biology; 2022: Elsevier.","DOI":"10.1016\/j.semcancer.2021.11.008"},{"key":"5048_CR37","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Torres AC, Lorenzo-Anota HY, Garc\u00eda-Ju\u00e1rez MG, Zarate-Trivi\u00f1o DG, Rodr\u00edguez-Padilla C. Chitosan gold nanoparticles induce different ROS-dependent cell death modalities in leukemic cells. Int J Nanomed. 2019:7173\u201390.","DOI":"10.2147\/IJN.S221021"},{"issue":"14","key":"5048_CR38","doi-asserted-by":"publisher","first-page":"8025","DOI":"10.1039\/C9RA00808J","volume":"9","author":"S Nag","year":"2019","unstructured":"Nag S, Manna K, Saha KD. Tannic acid-stabilized gold nano-particles are superior to native tannic acid in inducing ROS-dependent mitochondrial apoptosis in colorectal carcinoma cells via the p53\/AKT axis. RSC Adv. 2019;9(14):8025\u201338.","journal-title":"RSC Adv"},{"key":"5048_CR39","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s12013-013-9607-7","volume":"67","author":"CGP Doss","year":"2013","unstructured":"Doss CGP, Debajyoti C, Debottam S. Disruption of mitochondrial complexes in cancer stem cells through nano-based drug delivery: a promising mitochondrial medicine. Cell Biochem Biophys. 2013;67:1075\u20139.","journal-title":"Cell Biochem Biophys"},{"issue":"1","key":"5048_CR40","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1080\/21691401.2020.1814313","volume":"48","author":"H Malaikolundhan","year":"2020","unstructured":"Malaikolundhan H, Mookkan G, Krishnamoorthi G, Matheswaran N, Alsawalha M, Veeraraghavan VP, et al. Anticarcinogenic effect of gold nanoparticles synthesized from Albizia lebbeck on HCT-116 colon cancer cell lines. Artif cells Nanomed Biotechnol. 2020;48(1):1206\u201313.","journal-title":"Artif cells Nanomed Biotechnol"},{"issue":"1","key":"5048_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tjog.2023.10.003","volume":"63","author":"SS Bahreiny","year":"2024","unstructured":"Bahreiny SS, Bastani M-N, Aghaei M, Dabbagh MR, Mahdizade AH. Circulating Galectin-3 levels in women with polycystic ovary syndrome: A meta-analysis. Taiwan J Obstet Gynecol. 2024;63(1):37\u201345.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"16","key":"5048_CR42","doi-asserted-by":"publisher","first-page":"8956","DOI":"10.1021\/ic301050v","volume":"51","author":"B Yu","year":"2012","unstructured":"Yu B, Zhang Y, Zheng W, Fan C, Chen T. Positive surface charge enhances selective cellular uptake and anticancer efficacy of selenium nanoparticles. Inorg Chem. 2012;51(16):8956\u201363.","journal-title":"Inorg Chem"},{"key":"5048_CR43","doi-asserted-by":"publisher","first-page":"888740","DOI":"10.3389\/fphar.2022.888740","volume":"13","author":"J Ding","year":"2022","unstructured":"Ding J, Guo Y. Recent Advances in Chitosan and its Derivatives in Cancer Treatment. Front Pharmacol. 2022;13:888740.","journal-title":"Front Pharmacol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05048-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05048-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05048-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:08:01Z","timestamp":1789517281000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-05048-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5048"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05048-1","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethical Committee of Jundishapur University of Medical Sciences (ethical code: IR.AJUMS.REC.1400.270, project number: Th-0004). This study did not involve human participants or animal subjects. Therefore, informed consent was not required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"570"}}